Rothschild Investment LLC Rigel Pharmaceuticals Inc Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 10 shares of RIGL stock, worth $187. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$187% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RIGL
# of Institutions
9Shares Held
333KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY323KShares$6.05 Million0.76% of portfolio
-
Bergan Kdv Wealth Management, LLC10KShares$187,7000.0% of portfolio
-
Farther Finance Advisors, LLC San Francisco, CA695Shares$13,0450.0% of portfolio
-
Versant Capital Management, Inc132Shares$2,4770.0% of portfolio
-
Ever Source Wealth Advisors, LLC63Shares$1,1820.0% of portfolio
About RIGEL PHARMACEUTICALS INC
- Ticker RIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 172,836,000
- Market Cap $3.24B
- Description
- Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...